AU vs NEM

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite robust profitability metrics—ROE of 38.71%, operating margin of 42.49%, and strong YoY earnings growth of 147.2%—the stock trades at a premium valuation with a P/E of 22.56 and Price/Book of 6.98, above sector averages. Persistent earnings misses over the last four quarters and a weak technical trend score of 10/100 suggest caution, even as analyst consensus remains at 'buy'. The current price of $106.26 sits above the Graham Number of $40.18, reflecting high growth expectations rather than defensive value.

Newmont Corporation presents a dichotomy between strong operational fundamentals and significant valuation premiums. While the Piotroski F-Score of 4/9 indicates stable health and the balance sheet is pristine with a Debt/Equity ratio of 0.17, the stock trades at a substantial premium to its Graham Number ($66.88) and Intrinsic Value ($44.73). Recent quarterly earnings beats are impressive, yet bearish insider sentiment and a 0/100 technical trend suggest a lack of immediate conviction from internal stakeholders and market momentum. The overall outlook is neutral as strong profitability is offset by overvaluation and negative insider signals.